Who we are
Celluminova is a Swedish life science company focused on cancer stem cell biology. We develop small-molecule technologies designed to identify and target cell populations associated with tumor invasion, treatment resistance, and recurrence, initially focusing on aggressive brain tumors such as glioblastoma.
Our focus
Our current focus is fluorescence-guided surgery for malignant gliomas. Our lead candidate, p-HTMI, is being developed as a fluorescent imaging agent designed to enable visualization of glioma stem cells during surgery. Over time, our technology may offer opportunities for broader applications targeting cancer stem cells.
Our story
Celluminova grew out of persistent research aimed at finding a molecule capable of illuminating cancer stem cells. Years of dedicated work ultimately led to a fluorescent molecule with the desired properties, laying the scientific foundation for the company.
Our values
We are guided by scientific rigor, responsibility, and a clear focus on patients. These principles shape how we develop our science, build our company, and make long-term decisions.
Good ethics
Good ethics guide our decisions and help us act with integrity in everything we do
Scientifically sound
Our work is rooted in science and a strong research background
Responsibility
We take seriously the responsibility that comes with developing new technologies for patients
Our investors
We seek long-term investors who share our commitment to responsible science, a patient-focused approach, and sustainable company building.